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Clinical and experimental studies were carried out on plasma glucagon after total 
pancreatectomy in three patients with carcinoma of the pancreas and in 35 dogs, and 
following results were obtained. 
Results 
I . Plasma glucagon levels in totally pancreatectomized dogs. 
1) After total pancreatectomy, glucagon reacting to 30 K antibody decreased once but 
increased with the lapse of time when insulin was not administered. 
2) In the argininine test, glucagon showed a biphasic reaction in normal dogs, but a 
monophasic reaction in totally pancreatectomiz巴d dogs. This reaction declined 
three weeks after surgery. 
3) Blood samples were taken from the pancreaticoduodenal, the left gastroepiploic and 
the mesenteric veins, during and after arginine infusion for 30 minutes. Glucagon 
in the pancreaticoduodenal vein increased markedly, but there were no such 
prominent changes in the left-gastroepiploic and mesenteric veins, meanwhile, the 
level of glucagon in the Ieft-gastroepiploic vein increased remarkably in dogs one 
week after total pancreatectomy. 
Plasma glucagon levels in totally pancreatectomized patients. 
1) After total pancreatectomy, the glucagon reacting to 30K antibody decreased once 
but increased with the lapse of time when no insulin was administered. 
2) In the arginine test, plasma glucagon concentration did not increase in insulin 
Key words Totally pancreatectomized dogs, Pancreatectomized patients, Glucagon, Secretin, Arginine 
test. 




I . Effects of endog巴nousand exogenous secretin on plasma glucagon after total pancrerea・ 
tectomy in dogs. 
1) One clinical unit per kilogram of intravenously administered secretin (Eisai secrepan) 
caused no significant change in the plasma glucagon levels of normal dogs, but in 
totally pancreatectomized dogs, slight suppression of glucagon secretion was observtd. 
2) The administration of 7 clinical units of secretin caused a significant suppression 
of plasm glucagon in normal as well as totally pancr巴atectomizeddogs. 
3) Intraduodenally infused 0. lN HCI caused a rapid increase in the plasma secretin 
level, but had no significant effect on the plasma glucagon of normal dogs. 
-±) Aft巴rtotal pancreatectomy, basal s巴cretinlevels increased gradually, and endogenous 
secretin released by duodenal acidification brought about a significant suppression 
of plasma glucagon levels. 
Thus, in the totally pancreatectomized dogs, both plasma secretin levels and 
the suppressive effect of endogenous and exogenous secretin on plasma glucagon 
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ギニン注入開始後5分値 473土150pg/ml (p<0.01), 
10分値 297士89pg/mlで30分値 473土103pg/mlと
図の如く 2相性に増加し，末梢血グルカゴンにお
いても前値 50士4pg/mlで5分値 168土221pg/ml 
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より30分値 139土50pg/mlと増加し，末梢血グ
The changes in glucose and immunoreactive ルカゴン値は前値 44土11pg/mlで最高値は30
glucagon (IRG) levels after total pancreatectomy 
分で 102士37pg/mlどいずれも 1相性に増加し
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Fig. 2. The effects of arginine (0.5g/kg) 
infusion for 30 minutes on plasma 
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Fig. 3. The effects of arginine (0.5g/kg) infusion 
on plasma glucose, glucagon and insulin 
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Fig. 4. The effects of arginine (0.5g/kg) infus10n 
on plasma glucose, gl ucagon and insulin 
in totally pancreatectomi zed dogs, two 
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Fig. 5. The effects of arginine (0.5g/kg) infu・
sion on plasma glucose, glucagon anc 
insulin in totally pancreatectomized dogs, 
three weeks after surgery. 
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Fig. 6. Comparison of portal plasma glucagon 
levels in normal and totally pancreatec-
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Fig_ 7. Comparison of peripheral plasma glucagon 
in normal and totally pancreatectomized 














Fig. 8. Cmparison of plasma glucagon in the 
pancreatico:h.:odenal, left-gastroepiploic 
and mesenteric veins following arginine 
(0.5g/kg) infusion in normal and totaly 
pancreatectomized dogs, one week after 
surgery. GV: gastroepiploic vein, PV: 







アルギニン 0.2g/kgを1分間で on巴 shot静注しそ

















I I I I I j 』』
TOTAL 
PANCREATECTOMY 
T:l I I ノ
60 
40 
。 I ~ s "°"'' 12n山 18nou••













で 38pg/ml, 10分で21pg/ml. 30分で












’ lwook lw•ek• 
Fig. 9. The changes in immunoreactive glucagon (IRG) 
levels after total pancreatectomy in men. 

























ml, 10分で 67pg/ml,30分で 69pg/ml, 60分で 77
pg/mlと推移した．
症例2では術前の血中グルカゴン前値は 120pg/ml
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Fig. 10. Plasma glucagon response to arginine 
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Fig. 12. The effect of 1 clinical unit per kilogram 















た. (Fig. 13) 
グルカゴン値は前値 82土18pg/mlから 5分で
46土11pg/mlと下降した. (p<O. 05) (Fig. 13) 
一方末梢血中のインスリン値は前値 9:":2μu/ml；か
らセクレチン投与後3分で32±12μu/mlと増加し，
(p<O. 001）その後漸次下降した． (Fig. 13) 
血糖値ば，前値73土5mg/dlでセクレチン投与後も



















Fig. 13. The effect of 7 clinical units p巴rkilogram 。fsecretin injected intravenously into 
normal dogs. 
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Fig. 14. The changes in glucagon in the panc-
reaticoduodenal veins of normal dogs 
after injection of 7 clinical units of 
secretm. 
たセクレチン 7u/kg投与後10分で 49土12pg/mlと
著明に下降した. (p<O. 01) (Fig. 14）以後20分， 30

















血糖値は， 前値 184 31 pg/mlでセクレチン投与
後も有意の変動は見られなかった．
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Fig. 15, The effεct of 1 clinical unit of secretin 
injection in totally pancreatectomized 
dogs. 
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Fig, 16. The effect of 7 clinical units of secretin in 















投与した際のセクレチン値，消化管グルカゴン値，血 132土37pg/mlで注入開始後10分で 376. 81pg/ml, 
糖値の血中動態 IFig. 16) 15分で 534 77 pg/mlと増加し， (p<O. 01）以後漸
勝全切除後1週生存犬においてセクレチン7u/kgを 次下降した．
静注すると末梢、血中セクレチン値は，前値 143土52 血清グルカゴン値は前値 145二41pg/mlで塩酸注
pg/mlから 3分で 3200pg/ml以上となり，以後漸次 入後も有意の変動は見られなかった．
下降した． (Fig・16) インスリン値はih人前値 11土lμu/mlであり，注
勝全切除後の消化管グlレカコン値は，前値 170土19 入開始後15分で 35ゴ2111u/mlと増加した． (pく
pg/mlからセクレチン投与後3分で 157土16pg/ml, 0. 05) 
5分で 109ご 19pg1mlと下降し， (p<O. 01）以後10 7). 勝全切除後1週生存犬の十二指腸内 0.1 N糧自費
分で 153±18pg/mlとほぼがJ(1'Iに回復し，以後60分に 注入時におけるセクレチン値，消化管グルカゴン値の
227 
ml, 5分で 336±70pg/ml,10分で 220土68pg/mlと
































The effect of intraduodenal infusion 
of HCL (O.lN HCl 2.2 ml/Min for 30 
minutes) in normal dogs. 
Fig. 17. 
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Fig. 19. The efect of intraduodenal HCL infu-














~~IRS で算出すると術前 6. 94土 1. 08 ng/ml，術後
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The effect of intraduodenal HCL infu-
sion one week after total pancreatectomy. 


































Fig. 20. Comparison of secretin response in normal and 































































































































































































内に存在するソマトスタチンの欠如により，ソ 7 トス Il. 内因性および外因性セクレチンに対するグルカ
タチンのセクレチン分泌抑制機構か似綻することなど ゴン分泌反応
も考えられる．第4の給序として，Trimple29J等は糖 正常犬の血中クツレカゴン値は生理量の外因性セクν
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